Advancing Telestroke Care: A Prospective Observational Study

Stroke Clinical Trial

— ATC  

Official title:

Advancing Telestroke Care: A Prospective Observational Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01226862
• Other study ID #: NSA Telestroke
• Status: Completed
• Phase: N/A
• First received: October 20, 2010
• Last updated: December 4, 2013
• Start date: December 2010
• Est. completion date: December 2013

Study information

• Verified date: December 2013
• Source: National Stroke Association, United States
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study will promote the development and economic sustainability of telemedicine for acute stroke treatment.

Description:

The goal of this study is to promote the development and economic sustainability of telemedicine for acute stroke treatment. The study's objectives are 1) to determine if the use of telemedicine consultations for stroke patients will improve their care per guidelines compared to stroke patients treated by control hospitals; and 2) to determine if the care per guidelines provided via telemedicine consultations for stroke patients will be similar or equivalent to care per guidelines provided to stroke patients treated at hub hospitals.

The Advancing Telestroke Care study will establish treatment and outcomes in three distinct study cohorts: hub telemedicine hospital, spoke telemedicine hospital and non-telemedicine control hospital.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 508
• Est. completion date: December 2013
• Est. primary completion date: May 2013
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age greater than or equal to 18 years old

• Acute ischemic stroke within 12 hours of stroke onset

Exclusion Criteria:

• Life expectancy less than 90 days

• Patient unwilling to participate in study

Related Conditions & MeSH terms

• Stroke

Locations

Country	Name	City	State
United States	University of Southern California	Los Angeles	California

Sponsors (6)

Lead Sponsor	Collaborator
National Stroke Association, United States	California Pacific Medical Center, Mayo Clinic, Swedish Medical Center, University of Southern California, University of Utah

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	IV tPA administration	Correctness of decisions regarding IV tPA administration in acute stroke	Day 7/Discharge
Secondary	Multiple Study Assessments	There are 23 assessments, after stroke, for outcome measures. They include: hospital transfers, treatment with reperfusions therapies, treatment with antiplatelets, hypertension treatment, hyperglycemia treatment, hyperlipidemia treatment, symptomatic ICH, mortality, imaging/diagnostic data, stroke and rehab scale scores, number of hospitalizations since last assessment, hospital LOS, discharge location, number of physician visits, and work status.	Day 7 and/or Day 30 and/or Day 90 and/or at discharge